West Pharmaceutical Services, Inc.’s stock price takes a hit, dropping 3.98% to $269.08

West Pharmaceutical Services, Inc. (WST)

269.08 USD -11.15 (-3.98%) Volume: 0.64M

West Pharmaceutical Services, Inc.’s stock price stands at 269.08 USD, witnessing a decrease of -3.98% this trading session with a trading volume of 0.64M, reflecting a YTD percentage change of -17.84%, highlighting the volatility in the pharmaceutical sector.

Latest developments on West Pharmaceutical Services, Inc.

Recent stock movements for West Pharmaceutical Services Inc. (WST) have been influenced by various events. North Growth Management Ltd. acquired 4,000 shares of WST, while Invesco Ltd. boosted their stake in the company. On the other hand, XTX Topco Ltd sold 8,822 shares and Baird Financial Group Inc. reduced their stake in WST. Additionally, Arrowstreet Capital Limited Partnership holds $28.23 million in stock holdings for WST. These activities have contributed to fluctuations in the stock price of West Pharmaceutical Services Inc., which underperformed compared to its competitors on Monday. Wall Street Zen recently lowered their rating for WST to “Hold”.

West Pharmaceutical Services, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have provided bullish coverage on West Pharmaceutical Services Inc. In their research reports, they highlighted the company’s strong performance in key metrics, such as a 5% organic revenue increase and a 6% growth in adjusted EPS for the third quarter of 2025. They emphasized the expansion of high-value product components as a significant driver of future performance for West Pharmaceutical Services Inc.

Furthermore, Baptista Research‘s analysis of West Pharmaceutical Services Inc.’s second quarter of 2025 showcased a solid performance above expectations, with a 9.2% increase in net sales and 6.8% organic growth. They pointed out the company’s focus on high-value product components, particularly in areas like biologics and biosimilars, as key factors powering their optimism for West’s position in the injectable solutions market.

A look at West Pharmaceutical Services, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

West Pharmaceutical Services Inc has a promising long-term outlook based on its Smartkarma Smart Scores. With solid scores in resilience and momentum, the company is well-positioned to weather market fluctuations and maintain its growth trajectory. While the value and dividend scores are moderate, the growth score indicates potential for expansion in the future. Overall, West Pharmaceutical Services Inc seems to be a stable investment with room for growth.

West Pharmaceutical Services, Inc. is a company that adds value to the process of bringing new drug therapies and healthcare products to global markets. They specialize in packaging components, drug delivery systems, and contract laboratory services. With a focus on innovation and quality, West Pharmaceutical Services Inc is a key player in the healthcare industry, poised for long-term success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma